Press Releases

Filters
March 21, 2019

GenePOC obtains FDA clearance for its GenePOC™ Strep A test

Read more
February 26, 2019

Debiopharm International SA Initiates a Clinical Trial Phase II study evaluating afabicin in Bone and Joint Infections

Read more
February 14, 2019

Debiopharm International SA Initiates FUZE, a Clinical Trial Phase II study evaluating Debio 1347 in Advanced Solid Tumors harboring an…

Read more
January 29, 2019

Challenge pour la Qualité de vie du patient 2019 : l’appel à projets est ouvert !

Read more
January 7, 2019

Debiopharm Group regains the commercial rights to Trelstar® (Triptorelin pamoate) and looks for new partners in North America

Read more
November 26, 2018

Grand succès du 3e Challenge pour la Qualité de vie des patients

Read more
October 23, 2018

GenePOC® launches its GenePOC® CDiff test in Canada

Read more
October 11, 2018

Debiopharm International SA and the Paul Scherrer Institute announce a licensing agreement for the development of a novel targeted radiotherapeutic…

Read more
September 28, 2018

The Japanese Cancer Association and Debiopharm Group Announce Winners of the 2018 JCA-Mauvernay Award

Read more